Singapore markets closed
Straits Times Index
3,410.81 -29.07 (-0.85%) Nikkei
40,912.37 -1.28 (-0.00%) Hang Seng
17,799.61 -228.67 (-1.27%) FTSE 100
8,203.93 -37.33 (-0.45%) Bitcoin USD
56,541.44 +2,195.43 (+4.04%) CMC Crypto 200
1,172.06 -36.63 (-3.03%)
Monte Rosa Therapeutics, Inc. (GLUE)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 222.59M |
| Enterprise value | 74.88M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 185.08 |
| Price/book (mrq) | 1.46 |
| Enterprise value/revenue | 70.37 |
| Enterprise value/EBITDA | -0.78 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.38 |
| 52-week change 3 | -48.07% |
| S&P500 52-week change 3 | 26.25% |
| 52-week high 3 | 8.8400 |
| 52-week low 3 | 2.4400 |
| 50-day moving average 3 | 4.4627 |
| 200-day moving average 3 | 4.9848 |
Share statistics
| Avg vol (3-month) 3 | 218.31k |
| Avg vol (10-day) 3 | 350.12k |
| Shares outstanding 5 | 61.15M |
| Implied shares outstanding 6 | 61.15M |
| Float 8 | 28.63M |
| % held by insiders 1 | 0.71% |
| % held by institutions 1 | 80.51% |
| Shares short (14 Jun 2024) 4 | 1.98M |
| Short ratio (14 Jun 2024) 4 | 7.62 |
| Short % of float (14 Jun 2024) 4 | 5.94% |
| Short % of shares outstanding (14 Jun 2024) 4 | 3.24% |
| Shares short (prior month 15 May 2024) 4 | 2.31M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -3,284.49% |
Management effectiveness
| Return on assets (ttm) | -31.26% |
| Return on equity (ttm) | -68.28% |
Income statement
| Revenue (ttm) | 1.06M |
| Revenue per share (ttm) | 0.02 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -137.03M |
| Net income avi to common (ttm) | -135.28M |
| Diluted EPS (ttm) | -2.5100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 192.89M |
| Total cash per share (mrq) | 3.82 |
| Total debt (mrq) | 45.18M |
| Total debt/equity (mrq) | 29.62% |
| Current ratio (mrq) | 4.82 |
| Book value per share (mrq) | 3.04 |
Cash flow statement
| Operating cash flow (ttm) | -58.56M |
| Levered free cash flow (ttm) | -53.71M |
© 2024 Yahoo. All rights reserved.